GetTopicDetailResponse(id=9e788415941, topicName=胸腔積液患者, introduction=胸腔積液患者, content=null, image=null, comments=4, allHits=802, url=https://h5.medsci.cn/topic?id=84159, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=77795, tagList=[TagDto(tagId=77795, tagName=胸腔積液患者)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1809930, encodeId=137018099304f, content=<a href='/topic/show?id=9e788415941' target=_blank style='color:#2F92EE;'>#胸腔積液患者#</a>, objectTitle=BMC Cancer：奧希替尼治療EGFR突變的NSCLC合并胸腔積液患者的療效, objectType=article, longId=729662, objectId=b223e2966237, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b223e2966237, replyNumber=0, likeNumber=111, createdTime=2023-05-18, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b223e2966237, moduleTitle=BMC Cancer：奧希替尼治療EGFR突變的NSCLC合并胸腔積液患者的療效, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=b223e2966237)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1809929, encodeId=f1cc180992931, content=<a href='/topic/show?id=9e788415941' target=_blank style='color:#2F92EE;'>#胸腔積液患者#</a>, objectTitle=Thorac Cancer：Anlotinib（安羅替尼）治療小細(xì)胞肺癌伴有胸腔積液患者的療效和安全性, objectType=article, longId=221642, objectId=5305221642d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5305221642d2, replyNumber=0, likeNumber=89, createdTime=2022-03-02, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5305221642d2, moduleTitle=Thorac Cancer：Anlotinib（安羅替尼）治療小細(xì)胞肺癌伴有胸腔積液患者的療效和安全性, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=5305221642d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1809928, encodeId=283e18099281b, content=<a href='/topic/show?id=9e788415941' target=_blank style='color:#2F92EE;'>#胸腔積液患者#</a>, objectTitle=Lancet Oncol：預(yù)測(cè)惡性腫瘤性胸腔積液患者生存期和胸膜固定術(shù)效果的標(biāo)志物是, objectType=article, longId=144331, objectId=51d51443316a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=51d51443316a, replyNumber=0, likeNumber=82, createdTime=2019-01-10, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=51d51443316a, moduleTitle=Lancet Oncol：預(yù)測(cè)惡性腫瘤性胸腔積液患者生存期和胸膜固定術(shù)效果的標(biāo)志物是, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=51d51443316a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1809927, encodeId=9853180992e0d, content=<a href='/topic/show?id=9e788415941' target=_blank style='color:#2F92EE;'>#胸腔積液患者#</a>, objectTitle=JAMA： 惡性胸腔積液患者的疼痛和胸膜固定術(shù)療效和胸管大小有關(guān), objectType=article, longId=61032, objectId=8ad6610326c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ad6610326c, replyNumber=0, likeNumber=73, createdTime=2016-11-21, rootId=0, userName=klivis, userId=e87531, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ad6610326c, moduleTitle=JAMA： 惡性胸腔積液患者的疼痛和胸膜固定術(shù)療效和胸管大小有關(guān), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=8ad6610326c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
